Press release
Global Immunotoxin Market Overview Covering Forecast Market Size And Growth Rate 2033 | Pfizer Inc., Roche Holding AG, AbbVie Inc., Bayer AG, Bristol Myers Squibb, Thermo Fisher Scientific Inc
Immunotoxin Global Market Report 2024
As per the report, the immunotoxin market size has grown strongly in recent years. It will grow from $55.94 billion in 2023 to $60.97 billion in 2024 at a compound annual growth rate (CAGR) of 9.0%. The immunotoxin market size is expected to see strong growth in the next few years. It will grow to $86.29 billion in 2028 at a compound annual growth rate (CAGR) of 9.1%.
Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=15828&type=smp
Impact of Increasing Breast Cancer Incidence on the Immunotoxin Market
The increasing incidence of breast cancer is expected to propel the growth of the immunotoxin market going forward. Breast cancer refers to a type of cancer that forms in the cells of the breast. The rising incidence of breast cancer is primarily due to improved screening, lifestyle changes, and increased life expectancy. Immunotoxins help in breast cancer by targeting and killing cancer cells while sparing healthy cells, reducing side effects associated with traditional chemotherapy. For instance, in 2023 according to the American Cancer Society, a US-based non-profit organization, there were 300,590 new cases of breast cancer reported, showing an increase compared to the 290,560 cases reported in 2022. Therefore, an increasing incidence of breast cancer is driving the growth of the immunotoxin market.
FDA Approves First ADC For Metastatic Or Recurrent Cervical Cancer
Major companies operating in the immunotoxin market are focused on developing antibody-drug conjugates (ADCs) to enhance the specificity and efficacy of cancer treatment. ADCs are biopharmaceutical medicines that are intended to be used as targeted cancer treatments. Antibody-drug conjugates are made up of an antibody coupled to a cytotoxic medication, enabling targeted drug delivery to cancer cells that express a specific antigen. For instance, in April 2024, Pfizer Inc., a US-based pharmaceutical company, and Genmab A/S, a Denmark-based biotechnology company, received full U.S. Food and Drug Administration (FDA) approval for TIVDAK, a first antibody-drug conjugate designed to treat patients with metastatic or recurrent cervical cancer. The toxic payload of TIVDAK is monomethyl auristatin E, a microtubule-disrupting chemical that causes cell death. This novel mechanism leads to its efficiency in cancer treatment. TIVDAK showed statistically significant increases in overall survival, making it a promising alternative for individuals with recurrent or metastatic cervical cancer.
The immunotoxin market covered in this report is segmented -
1) By Type: Anthrax Based Toxins, Diphtheria Toxin (DT) And Derivatives, Pseudomonas Exotoxin (PE) And Derivatives, Ribosome Inactivating Proteins Based Immunotoxins, Ribonucleases-Based Immunotoxins, Other Types
2) By Application: Solid Tumors, Leukemias, Other Applications
3) By End User: Hospitals And Clinics, Cancer And Radiation Therapy Centers, Research Labs, Other End-Users
Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=15828&type=discount
Major companies operating in the immunotoxin market are Pfizer Inc., Roche Holding AG, AbbVie Inc., Bayer AG, Bristol Myers Squibb, Thermo Fisher Scientific Inc., AstraZeneca plc, Merck KGaA, BioNTech SE, Ipsen Pharma, Seagen Inc., Orion Corporation, GenScript, Cytek Biosciences, MacroGenics Inc., Sutro Biopharma Inc., Sorrento Therapeutics Inc., Innate Pharma Inc., Cayman Chemical, ImmunoGen Inc., Mersana Therapeutics, Molecular Templates Inc., Celldex Therapeutics, CytImmune Sciences Inc., Enzo Life Sciences Inc.
Contents of the report:
1. Executive Summary
2. Immunotoxin Market Report Structure
3. Immunotoxin Market Trends And Strategies
4. Immunotoxin Market - Macro Economic Scenario
5. Immunotoxin Market Size And Growth
…..
27. Immunotoxin Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/immunotoxin-global-market-report
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ "
Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Immunotoxin Market Overview Covering Forecast Market Size And Growth Rate 2033 | Pfizer Inc., Roche Holding AG, AbbVie Inc., Bayer AG, Bristol Myers Squibb, Thermo Fisher Scientific Inc here
News-ID: 3583429 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Immunotoxin
Immunotoxin Market Future Business Opportunities 2025-2032 | Amgen • AbbVie †…
Coherent Market Insights has released a report titled "Immunotoxin Market: Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2025-2032", which includes market percentage records and a thorough enterprise analysis. This report looks at the market's competition, geographic distribution, and growth potential. This comprehensive report encompasses industry performance, critical success factors, risk assessment, manufacturing prerequisites, project expenses, economic analysis, anticipated return on investment (ROI), and profit margins.
➤ To Purchase This Premium…
2025-2034 Immunotoxin Market Outlook: Key Drivers, Emerging Challenges, and Stra …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Immunotoxin Industry Market Size Be by 2025?
The immunotoxin market has experienced significant expansion in the past few years. The market size is forecasted to increase from $60.97 billion in 2024 to $66 billion in 2025, reflecting a compound annual growth rate (CAGR) of 8.3%. This…
Emerging Immunotoxin Market Trends: FDA Approves First ADC For Metastatic Or Rec …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Immunotoxin Market Size Growth Forecast: What to Expect by 2025?
In recent years, the immunotoxin market has seen significant growth. The market size is projected to expand from $60.97 billion in 2024 to $66.62 billion in 2025, with a compound annual growth rate (CAGR) of 9.3%. Factors such as…
Impact of Increasing Breast Cancer Incidence on the Immunotoxin Market: A Key Dr …
The Immunotoxin Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Immunotoxin Market Size and Its Estimated Growth Rate?
The immunotoxin market size has grown strongly in recent years. It will grow from $60.97 billion in 2024 to $66.62 billion in 2025 at…
Immunotoxin Market Outlook: Global Size, Regional Overview, and Leading Company …
29 March 2025, Metatech Insights - Immunotoxin Market industry achieved a market size of USD 168.5 Million in 2024 and is forecast to climb to USD 388.9 Million by 2035, fueled by a CAGR of approximately 7.90% throughout 2024-2035.
The Immunotoxin Market Report is the outcome of extensive research and analysis conducted by our team of experienced market researchers. It covers a wide range of critical factors impacting the Immunotoxin Market…
Immunotoxin Market Set to Reach $93.93 Billion by 2029 with 9% Yearly Growth
Which drivers are expected to have the greatest impact on the over the immunotoxin market's growth?
The growing incidence of breast cancer is expected to stimulate the immunotoxin market. Breast cancer, characterized by the abnormal growth of cells in the breast, is increasing due to improved screening, lifestyle changes, and longer life expectancies. Immunotoxins target and kill cancer cells while minimizing damage to healthy cells, offering a less harmful alternative to…
